Advancing Metabolic Infant Nutrition: The Latest in Early Years Formula Innovation
Event date: 2/24/2026 1:00:00 PM EST
Join us for a 30-minute educational webinar with Rachel Powers, RD. Learning Objectives:
- Explore the latest amino acid profile enhancements in Anamix® Early Years for MSUD, GA‑1, and MMA/PA and understand the clinical rationale driving these updates.
- Recognize the expanded indication for GA-1 Anamix Early Years to include pyridoxine‑dependent epilepsy (PDE) and learn best practices for using lysine‑free formulas in PDE management.
- Discover how the unique prebiotic oligosaccharide blend in Early Years supports gut health and the immune system.